DHR logo Danaher Corporation +
Danaher Corporation
+

Danaher Corporation (DHR) Business News

Track Danaher Corporation in real time with a live news feed covering Danaher Corporation stock news, official press releases, company announcements, and an archive of historical Danaher Corporation news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Danaher to Present at Bank of America Securities Healthcare Conference

PRNewsWire

4:15 PM | Wednesday | May 6, 2026

news photo
Loading...

WASHINGTON, May 6, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 13, 2026 at 11:20 a.m.

Read full article redirect
4:15 PM | Wednesday | May 6, 2026

Danaher to Present at Bank of America Securities Healthcare Conference

PRNewsWire

WASHINGTON, May 6, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 13, 2026 at 11:20 a.m.

Read full article arrow
News Thumbnail
4:30 PM | Tuesday | May 5, 2026

Danaher Announces Quarterly Dividend

PRNewsWire

WASHINGTON, May 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 31, 2026 to holders of record on June 26, 2026. ABOUT DANAHER Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.

Read full article arrow
News Thumbnail
9:00 AM | Monday | May 4, 2026

Masimo Shareholders Approve Acquisition by Danaher

Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026 (the “Merger Agreement”), by and among Masimo, Danaher Corporation (“Danaher”) (NYSE: DHR) and Mobius Merger Sub, Inc. (the “Merger Sub”) at Masimo's special meeting of stockholders held virtually on May 1, 2026 (.

Read full article arrow
News Thumbnail
7:15 PM | Wednesday | Apr 22, 2026

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

PRNewsWire

WASHINGTON, April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"): €500,000,000 principal amount of floating rate senior notes due 2028 at an offering price of 100.000% of the principal amount; €750,000,000 principal amount of 3.250% senior notes due 2030 at an offering price of 99.934% of the principal amount; €750,000,000 principal amount of 3.625% senior notes due 2034 at an offering price of 99.
918% of the principal amount; and €1,000,000,000 principal amount of 4.000% senior notes due 2038 at an offering price of 99.953% of the principal amount (collectively, the "senior notes"). Danaher estimates that the net proceeds from the sale of the senior notes will be approximately €2.98 billion, after deducting the... Read more

Read full article arrow
News Thumbnail
6:00 AM | Tuesday | Apr 21, 2026

Danaher Reports First Quarter 2026 Results

PRNewsWire

WASHINGTON, April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026.  All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.

Read full article arrow
News Thumbnail
3:01 AM | Monday | Apr 13, 2026

Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes

PRNewsWire

Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing  BREA, Calif., April 13, 2026 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad availability of a high-throughput host‑response test that helps clinicians differentiate between bacterial and viral infections in approximately 20 minutes.

Read full article arrow
News Thumbnail
3:47 PM | Thursday | Mar 12, 2026

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Read full article arrow
News Thumbnail
4:30 PM | Tuesday | Feb 24, 2026

Danaher Announces Quarterly Dividend

PRNewsWire

WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026. ABOUT DANAHER Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.

Read full article arrow
News Thumbnail
4:05 PM | Tuesday | Feb 24, 2026

Danaher to Present at TD Cowen Health Care Conference

PRNewsWire

WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 3, 2025 at 1:50 p.m.

Read full article arrow
News Thumbnail
8:02 AM | Tuesday | Feb 17, 2026

Masimo to be Acquired by Danaher for $180.00 Per Share

Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (“Danaher”) will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the “Transaction”). The Transaction has been unanimously approved by both Masimo's Board of Directors and Danaher's Board of Directors.
Masimo will become.

Read full article arrow
News Thumbnail